Litigation Details for VANDA PHARMACEUTICALS INC. v. APOTEX INC. (D.N.J. 2022)
✉ Email this page to a colleague
VANDA PHARMACEUTICALS INC. v. APOTEX INC. (D.N.J. 2022)
Docket | ⤷ Try a Trial | Date Filed | 2022-12-26 |
Court | District Court, D. New Jersey | Date Terminated | 2023-02-09 |
Cause | 35:271 Patent Infringement | Assigned To | Claire Claudia Cecchi |
Jury Demand | Plaintiff | Referred To | Jessica S. Allen |
Parties | VANDA PHARMACEUTICALS INC. | ||
Patents | 10,071,977 | ||
Attorneys | JUSTIN TAYLOR QUINN | ||
Firms | Robinson Miller LLC, Ironside Newark | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in VANDA PHARMACEUTICALS INC. v. APOTEX INC.
Details for VANDA PHARMACEUTICALS INC. v. APOTEX INC. (D.N.J. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-02-09 | 47 | Opinion | , 2018) (adding U.S. Patent No. 10,071,977); see Def. Br. at 5 (noting 15 patents asserted in total).…5. Vanda holds multiple patents relating to tasimelteon. The suit for patent infringement underlying…motion to transfer concerns U.S. Patent No. 11,285,129 (the ’129 patent), which issued on March 29, 2022…related patents. 2 See Compl. ¶¶ 22-39, Vanda Pharms. 2 Vanda originally asserted six patents but added…later-issued patents to the Delaware litigation, Vanda would not assert any additional patents against Teva | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |